The ground is shifting beneath the feet of the pharmaceutical industry. The long-standing formula for commercial success used to include building massive, dedicated sales forces. Now, it has become a liability in an era of patent cliffs, cost pressures, and a pipeline focused on high-science therapies.
As companies rethink their entire commercial model, the demand for outsourcing partners is exploding, with growth projected to leap to a staggering 20-40% in the coming years. However, one critical question remains:
Are the partners of yesterday equipped for the challenges of today?
For large pharma, choosing a partner is no longer about filling headcount; it’s about finding a strategic lever for success. Thriving in this new environment requires moving beyond transactional relationships and embracing a new kind of partnership built for the future of medicine.
Learn how EVERSANA’s modern, integrated approach delivers the flexibility, expertise, and owner’s mindset needed to navigate this complex landscape.
Author
Krista works with pharmaceutical and biotech companies to find design-effective commercialization solutions. With more than 20 years of experience in the pharmaceutical industry, Krista is an experienced sales representative and district manager, with strong…
Susan is a strategic commercial leader with nearly 30 years of experience in the life sciences industry including sales leadership, marketing, and commercial effectiveness. She understands the complexities of executing commercial strategies in today’s…